Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 882521-63-3 | MDL No. : | MFCD11846606 |
Formula : | C6H5BrN4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DAYYXZOMYRSLBX-UHFFFAOYSA-N |
M.W : | 213.03 | Pubchem ID : | 54594025 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 45.09 |
TPSA : | 56.21 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.83 cm/s |
Log Po/w (iLOGP) : | 1.59 |
Log Po/w (XLOGP3) : | 1.09 |
Log Po/w (WLOGP) : | 1.08 |
Log Po/w (MLOGP) : | 1.58 |
Log Po/w (SILICOS-IT) : | 0.45 |
Consensus Log Po/w : | 1.16 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.45 |
Solubility : | 0.751 mg/ml ; 0.00352 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.86 |
Solubility : | 2.92 mg/ml ; 0.0137 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.21 |
Solubility : | 1.3 mg/ml ; 0.00612 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.94 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87.4% | With hydroxylamine hydrochloride; N-ethyl-N,N-diisopropylamine In ethanol at 25℃; for 24 h; Reflux | A mixture of hydroxylamine hydrochloride (20.0 g, 288 mmol) and N-ethyldiisopropylamine (30.1 ml, 173 mmol) in ethanol (367 ml) is stirred for a few minutes at room temperature and the mixture is added to l-ethoxycarbonyl-3-(4-bromo-pyridin-2-yl)-thiourea (17.5 g, 57.5 mmol). The resulting mixture is refluxed for 1 day. The solvent is evaporated and 100 ml water is added to the residue. The suspension is stirred for 10 minutes, the solid is collected by filtration, washed with water and dried affording 7-bromo-[l,2,4]triazolo[l,5-a]pyridin-2-amine (10.71 g, 87.4percent) as a light yellow solid. Mp.: 190-2°C. MS: m/z= 213.0, 215.0 (M+H+). |
86% | With hydroxylamine hydrochloride; N-ethyl-N,N-diisopropylamine In methanol; ethanol at 20 - 60℃; for 5 h; | To a stirred suspension/solution of hydroxylamine hydrochloride (375 mg, 5.40 mmol) and diisopropylethylamine (419 mg, 3.24 mmol) in MeOH/EtOH (1 :1 , 2 mL) was added compound 2 as a solid. This mixture was stirred at room temperature for 2 h, giving a pale yellow suspension, followed by a further 3h, at 600C. The reaction mixture was allowed to cool, diluted with CH2CI2 (100 mL), which was then washed with water (2x80 mL) and brine (80 mL). This solution was dried (Na2SO4) and the solvent removed under reduced pressure to give 7-bromo-[1 ,2,4]triazolo[1 ,5-a]pyridin-2-ylamine (3) LCMS (APCI+) 213, 215. |
83% | With hydroxylamine hydrochloride; N-ethyl-N,N-diisopropylamine In methanol; ethanol at 20℃; Reflux | 2.2 7-Bromo-[l,2,4]triazolo[l,5-a]pyridin-2-ylamine (3); To a suspension of hydroxylamine hydrochloride (4.7g, 68mmol) in EtOH/MeOH (1 :1, 16OmL) was added JV,jV-diisopropylethylamine (7.2mL, 41mmol), the mixture was stirred at room temperature (2O0C) for Ih. l-(4-Bromo-pyridin-2-yl)-3-carboethoxy-thiourea (2) (4.13g, 13.6mmol) was then added and the mixture slowly heated to reflux (Note: bleach scrubber required to quench H2S evolved). After 2h at reflux the mixture was allowed to cool and filtered to collect the precipitated solid. The collected solid was washed successively with water (10OmL), EtOH/MeOH (1 :1, 10OmL) and diethyl ether (5OmL) then air-dried to afford the title compound as a white solid (2.4g, 83percent). No further purification was required. LCMS (method C), (M+H+) 213/215, Rt = 1.48 min. 1H NMR (de-DMSO) δ 8.50 (d, IH), 7.66 (d, IH), 7.03 (dd, IH), 6.15 (brs, 2H). |
78.8% | With hydroxylamine hydrochloride; N-ethyl-N,N-diisopropylamine In ethanol at 25℃; for 24 h; Reflux | b) 7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine A mixture of hydroxylamine hydrochloride (20.7 g, 298 mmol) and N-ethyldiisopropylamine (23.1 g, 31.2 ml, 179 mmol) in ethanol (380 ml) is stirred for a few minutes at 25° C. The mixture is then added to 1-ethoxycarbonyl-3-(4-bromo-pyridin-2-yl)-thiourea (18.13 g, 59.6 mmol) and the resulting mixture is refluxed for 1 day. The solvent is evaporated to dryness and the residue triturated for 10 minutes with water (100 ml). The solid is collected by filtration, washed with water and dried affording 7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine (10 g, 78.8percent) as a light yellow solid. mp.: 190-2° C. MS: m/z=212.9, 215.0 (M+H+). |
59% | With hydroxylamine hydrochloride; diisopropylamine In methanol; ethanol at 20 - 60℃; for 5 h; | 10.61 g (152.677 mmol) of hydroxylamine hydrochloride and 11.84 g (91.606 mmol) N,N- diisopropylamine were dissolved in 60 ml methanol/ethanol (v/v = 1 :1). B-6 g (28.273 mmol) of the compound from example 109A was added and the mixture was stirred at room temperature for 2 h and at 600C for 3 h. After cooling, water and ethyl acetate were added, the organic phase was removed and the aqueous phase was extracted twice with ethyl acetate. The combined organic phases were dried over sodium sulfate, concentrated in a rotary evaporator and the residue was dried under high vacuum. We obtained 4.05 g (59percent of theor.) of the target compound at a purity of 87percent according to LC-MS.LC-MS (method 10): Rt = 0.50 min; MS (EIpos): m/z = 213 [M+H]+.1H-NMR (400 MHz, DMSO-D6): δ [ppm] = 6.13 (s, 2H), 7.02 (dd, IH), 7.65 (dd, IH), 8.49 (dd, IH). |
4 g | With hydroxylamine hydrochloride; N-ethyl-N,N-diisopropylamine In methanol; ethanol at 60℃; for 3 h; | To a solution of 2-amino-4-bromopyridine (5.0 g, 28.90 mmol) in dichloromethane (120 mL) at 0 °C, was added ethoxycarbonyl-isothiocyanate (3.41 mL, 28.90 mmol) dropwise for 30 min and stirred at room temperature for 12 h. The solvent was evaporated in vacuo to leave a yellow solid which was triturated with hexane, filtered and air dried. The crude was taken to the next step without any further purification. To a suspension of hydroxylamine hydrochloride (3.61 mL, 86.68 mmol) in a mixture of EtOH/MeOH (1:1, 200 mL) was added N,N-diisopropylethylamine (25 mL, 144.50 mmol) and the mixture was stirred at room temperature for 2 h. The compound 1-(6-bromo-pyridin-2-yl)-3-carboethoxythiourea which was isolated in the previous step was then added and the mixture was slowly heated to 60 °C and stirred for 3 h. The reaction mixture was cooled, and the precipitated solid was filtered. The solid was washed with a mixture of EtOH/MeOH (1:1, 25 mL) followed by diethyl ether (15 mL) and air dried to afford the title compound as white solid. Yield: 65percent (4.00 g) (adapted from 3). 1H NMR (600 MHz, DMSO-d6) δ 8.49 (d, J = 7.2 Hz, 1H), 7.65 (d, J = 1.8 Hz, 1H), 7.01 (dd, J = 7.2, 1.8 Hz, 1H), 6.13 (s, 2H). HRMS-ESI (+) m/z calculated for C6H6BrN4, 212.9776 [M+H]+; found: 212.9780 |
[ 947248-68-2 ]
6-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine
Similarity: 0.91
[ 1053655-66-5 ]
7-Bromo-[1,2,4]triazolo[1,5-a]pyridine
Similarity: 0.91
[ 1124382-72-4 ]
2-Amino-8-bromo[1,2,4]triazolo[1,5-a]pyridine
Similarity: 0.86
[ 1159812-31-3 ]
7-Bromo-2-methyl-[1,2,4]triazolo[1,5-a]pyridine
Similarity: 0.84
[ 356560-80-0 ]
6-Bromo-[1,2,4]triazolo[1,5-a]pyridine
Similarity: 0.83
[ 947248-68-2 ]
6-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine
Similarity: 0.91
[ 1124382-72-4 ]
2-Amino-8-bromo[1,2,4]triazolo[1,5-a]pyridine
Similarity: 0.86
[ 1010120-55-4 ]
5-Bromo[1,2,4]triazolo[1,5-a]pyridin-2-amine
Similarity: 0.82
[ 1092394-16-5 ]
2-Amino-[1,2,4]triazolo[1,5-a]pyridin-6-ol hydrobromide
Similarity: 0.81
[ 1239647-60-9 ]
6-Chloro-[1,2,4]triazolo[1,5-a]pyridin-2-amine
Similarity: 0.78
[ 947248-68-2 ]
6-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine
Similarity: 0.91
[ 1053655-66-5 ]
7-Bromo-[1,2,4]triazolo[1,5-a]pyridine
Similarity: 0.91
[ 1124382-72-4 ]
2-Amino-8-bromo[1,2,4]triazolo[1,5-a]pyridine
Similarity: 0.86
[ 1159812-31-3 ]
7-Bromo-2-methyl-[1,2,4]triazolo[1,5-a]pyridine
Similarity: 0.84
[ 356560-80-0 ]
6-Bromo-[1,2,4]triazolo[1,5-a]pyridine
Similarity: 0.83